BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25786136)

  • 1. Nephroprotective effect of heparanase in experimental nephrotic syndrome.
    Assady S; Alter J; Axelman E; Zohar Y; Sabo E; Litvak M; Kaplan M; Ilan N; Vlodavsky I; Abassi Z
    PLoS One; 2015; 10(3):e0119610. PubMed ID: 25786136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gene expression of heparanase in peripheral blood leukocytes from rats with nephrotic syndrome and its relationship to proteinuria].
    Yan Y; Wang Z; Luo W
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 35(4):489-91. PubMed ID: 15291107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior.
    Zcharia E; Metzger S; Chajek-Shaul T; Aingorn H; Elkin M; Friedmann Y; Weinstein T; Li JP; Lindahl U; Vlodavsky I
    FASEB J; 2004 Feb; 18(2):252-63. PubMed ID: 14769819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass.
    Kram V; Zcharia E; Yacoby-Zeevi O; Metzger S; Chajek-Shaul T; Gabet Y; Müller R; Vlodavsky I; Bab I
    J Cell Physiol; 2006 Jun; 207(3):784-92. PubMed ID: 16514606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of yiqiyangyin recipe on heparanase and nephrin in rats with adriamycin-induced nephropathy.
    Sun W; He Y; Yu J; Lin Y; Wang Y; Gao X; Wang Y; Zhao Z; Liu X
    J Tradit Chin Med; 2013 Jun; 33(3):334-42. PubMed ID: 24024329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparanase Increases Podocyte Survival and Autophagic Flux after Adriamycin-Induced Injury.
    Abu-Tayeh Suleiman H; Said S; Ali Saleh H; Gamliel-Lazarovich A; Haddad E; Minkov I; Zohar Y; Ilan N; Vlodavsky I; Abassi Z; Assady S
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelioration of anti-cancer agent adriamycin-induced nephrotic syndrome in rats by Wulingsan (Gorei-San), a blended traditional Chinese herbal medicine.
    He L; Rong X; Jiang JM; Liu PQ; Li Y
    Food Chem Toxicol; 2008 May; 46(5):1452-60. PubMed ID: 18215452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545.
    Abassi Z; Hamoud S; Hassan A; Khamaysi I; Nativ O; Heyman SN; Muhammad RS; Ilan N; Singh P; Hammond E; Zaza G; Lupo A; Onisto M; Bellin G; Masola V; Vlodavsky I; Gambaro G
    Oncotarget; 2017 May; 8(21):34191-34204. PubMed ID: 28388547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 22-oxa-calcitriol on podocyte injury in adriamycin-induced nephrosis.
    Lydia A; Asanuma K; Nonaka K; Takagi M; Jeong KH; Kodama F; Asao R; Asanuma E; Prodjosudjadi W; Tomino Y
    Am J Nephrol; 2012; 35(1):58-68. PubMed ID: 22189044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metallothionein over-expression in podocytes reduces adriamycin nephrotoxicity.
    Yang L; Zheng S; Epstein PN
    Free Radic Res; 2009 Feb; 43(2):174-82. PubMed ID: 19204870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase activity is dysregulated in children with steroid-sensitive nephrotic syndrome.
    Holt RC; Webb NJ; Ralph S; Davies J; Short CD; Brenchley PE
    Kidney Int; 2005 Jan; 67(1):122-9. PubMed ID: 15610235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of heparanase in mice promoted megakaryopoiesis.
    Tan YX; Cui H; Wan LM; Gong F; Zhang X; Vlodavsky I; Li JP
    Glycobiology; 2018 May; 28(5):269-275. PubMed ID: 29471321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tripterygium glycoside fraction n2 ameliorates adriamycin-induced nephrotic syndrome in rats by suppressing apoptosis.
    Wang XW; Tian RM; Yang YQ; Wang K; Li EN; Han XD; Bao K; Mao W; Xu HT; Liu B; Xu P
    J Ethnopharmacol; 2020 Jul; 257():112789. PubMed ID: 32234597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of host heparanase in promoting tumor growth and metastasis.
    Zhang GL; Gutter-Kapon L; Ilan N; Batool T; Singh K; Digre A; Luo Z; Sandler S; Shaked Y; Sanderson RD; Wang XM; Li JP; Vlodavsky I
    Matrix Biol; 2020 Nov; 93():25-42. PubMed ID: 32534153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system.
    Kramer A; van den Hoven M; Rops A; Wijnhoven T; van den Heuvel L; Lensen J; van Kuppevelt T; van Goor H; van der Vlag J; Navis G; Berden JH
    J Am Soc Nephrol; 2006 Sep; 17(9):2513-20. PubMed ID: 16899518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heparanase expression of peripheral blood cells in steroid responsive nephrotic syndrome patients].
    Yan Y; Wang Z; Tao YH
    Zhonghua Er Ke Za Zhi; 2004 Mar; 42(3):199-201. PubMed ID: 15144715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparanase in Acute Pancreatitis.
    Khamaysi I; Hamo-Giladi DB; Abassi Z
    Adv Exp Med Biol; 2020; 1221():703-719. PubMed ID: 32274733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gene expressions of xylosyltransferase and heparanase in renal tissue of rat with adriamycin nephropathy and relevance for proteinuria].
    Luo W; Wang Z
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 38(6):965-8. PubMed ID: 18095597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult and paediatric patients with minimal change nephrotic syndrome show no major alterations in glomerular expression of sulphated heparan sulphate domains.
    Wijnhoven TJ; Geelen JM; Bakker M; Lensen JF; Rops AL; Kramer AB; Navis G; van den Hoven MJ; van der Vlag J; Berden JH; Wetzels JF; van den Heuvel LP; Monnens LA; van Kuppevelt TH
    Nephrol Dial Transplant; 2007 Oct; 22(10):2886-93. PubMed ID: 17526541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury.
    Masola V; Zaza G; Gambaro G; Onisto M; Bellin G; Vischini G; Khamaysi I; Hassan A; Hamoud S; Nativ O; Heyman SN; Lupo A; Vlodavsky I; Abassi Z
    PLoS One; 2016; 11(7):e0160074. PubMed ID: 27467172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.